Inactive Instrument

News Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board

Equities

US21833P1030

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Apr. 02	Corbus Pharmaceuticals Holdings, Inc. Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC	CI
Mar. 13	Corbus Pharmaceuticals Files Mixed Shelf	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting	Apr. 24	AQ
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC	Apr. 02	AQ
Corbus Pharmaceuticals Holdings, Inc. Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC	Apr. 02	CI
Corbus Pharmaceuticals Files Mixed Shelf	Mar. 13	MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $58 From $51, Maintains Outperform Rating	Mar. 13	MT
Health Care Climbs on Risk Appetite -- Health Care Roundup	Mar. 12	DJ
Corbus Pharmaceuticals: Q4 Earnings Snapshot	Mar. 12	AQ
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	Mar. 12	AQ
Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
North American Morning Briefing : Inflation Data -2-	Mar. 12	DJ
North American Morning Briefing : Powell Still in -2-	Mar. 07	DJ
Jefferies Upgrades Corbus Pharmaceuticals Holdings to Buy From Hold	Mar. 06	MT
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit	Mar. 06	AQ
Corbus Pharmaceuticals Holdings, Inc. Appoints Dominic Smethurst as Chief Medical Officer	Feb. 28	CI
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer	Feb. 28	AQ
Corbus Pharmaceuticals Holdings, Inc. Announces Resignation of Rachael Brake, Ph.D., as Chief Scientific Officer, Effective from February 19, 2024	Feb. 06	CI
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	AQ
Corbus Pharmaceuticals Closes $94.5 Million Public Offering	Feb. 02	MT
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares	Feb. 02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board

Equities

US21833P1030

Summary

Filters